Glycated and Non-Glycated Human Alpha-1 Antitrypsin in Hyperglycemic Wound Healing: In Vivo and In Vitro Models
Authors:
- Idan FarberIFIdan Farber
- Alon NaumchikAlon Naumchik
- Yosef IstoylerYIYosef Istoyler
- Melody ZaknounMZMelody Zaknoun
- Yuval AnavYAYuval Anav
- Lihie ShefferLSLihie Sheffer
- Ronen SchusterRSRonen Schuster
- Dor HalpernDHDor Halpern
- Vladimir FridmanVFVladimir Fridman
- Merav Cohen-LahavMCMerav Cohen-Lahav
- Samuel CohenSCSamuel Cohen
- Eli C. LewisELEli C. Lewis
Open Access
Abstract
Impaired wound healing is a major cause of morbidity among patients with diabetes. Human α1-antitrypsin (hAAT) promotes the resolution of injured tissues. In hyperglycemic conditions, circulating hAAT is likely to undergo glycation, yet it is unknown whether its reparative properties are preserved. We hypothesized that clinical-grade hAAT treatment, but not deliberately glycated hAAT (gly-hAAT), would promote wound repair under hyperglycemic conditions. Mice were rendered hyperglycemic, excisional wounding was performed, and wounds were treated with topical albumin or hAAT every three days. The wound area was assessed, and samples were collected for histology and gene expression analysis. Gly-hAAT was generated from clinical-grade hAAT, after which in vitro RAW 264.7 macrophage responses and re-epithelialization of A549 cells were assessed. Gap closure was further assessed using sera from a human cohort (prospective samples from 10 patients with poorly controlled diabetes at Soroka University Medical Center, Beer-Sheva, Israel, 2018). Group comparisons were performed using one-way ANOVA with Tukey’s post hoc test. hAAT accelerated in vivo wound closure and in vitro A549 cell gap closure, accompanied by an anti-inflammatory IL-1Ra/IL-1β gene expression profile. In contrast, gly-hAAT inhibited normoglycemic mouse wound closure, evoked an inflammatory response in macrophages, and interfered with A549 cell gap closure; concomitant hAAT treatment improved gap closure. Similarly, patient serum inhibited A549 gap closure, and concomitant hAAT treatment improved gap closure. Importantly, inferential statistical analysis was not performed on this outcome due to the small and heterogeneous human cohort. In conclusion, hAAT accelerated wound closure in hyperglycemic mice and in A549 cells, whereas gly-hAAT promoted inflammatory responses and impaired wound closure, a trend reversed by native hAAT. These findings support the concept that glycation undermines the beneficial functions of circulating hAAT and provides a mechanistic insight into the pathophysiology of diabetic wound healing. Further studies are warranted to evaluate clinical-grade hAAT as a potential therapeutic for hyperglycemia-associated impaired wound healing.Keywords
Funding Information
- Israeli Ministry of Defense (1884-2018)
- The Diane Lynn Family Foundation
This publication has 52 references indexed in Scilit:
- Mouse models of diabetes-related ulcers: a systematic review and network meta-analysisEBioMedicine, 2023
- Distinct anti-inflammatory properties of alpha1-antitrypsin and corticosteroids reveal unique underlying mechanisms of actionCellular Immunology, 2020
- Effect of advanced glycation end product on paraoxonase 2 expression: Its impact on endoplasmic reticulum stress and inflammation in HUVECsLife Sciences, 2020
- Glycated albumin stimulates expression of inflammatory cytokines in muscle cellsCytokine, 2020
- The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammagingBiogerontology, 2019
- Advanced Glycated End Products Alter Neutrophil Effect on Regulation of CD4+ T Cell Differentiation Through Induction of Myeloperoxidase and Neutrophil Elastase ActivitiesInflammation, 2018
- The Interleukin-1 Family2016
- Targeting Imbalance between IL-1β and IL-1 Receptor Antagonist Ameliorates Delayed Epithelium Wound Healing in Diabetic Mouse CorneasThe American Journal of Pathology, 2016
- Dilatation of the ascending aorta and serum alpha 1-antitrypsin level in patients with bicuspid aortic valveHeart and Vessels, 2011
- Pulmonary epithelial expression of human α1-antitrypsin in transgenic mice results in delivery of α1-antitrypsin protein to the interstitiumJournal of Molecular Medicine, 1999